Abacus Health Products - CSE: ABCS 9.85 CAD

Search Results for:

Abacus CEO Perry Antelman to Speak at the Inaugural Institutional Capital & Cannabis Conference Europe

  Abacus CEO Perry Antelman to Speak at the Inaugural Institutional Capital & Cannabis Conference Europe Woonsocket, RI – June 13, 2019 – Abacus Health Products (“Abacus” or the “Company”) (CSE: ABCS) CEO Perry Antelman will be a panel participant at the inaugural Institutional Capital & Cannabis Conference Europe (IC3 Europe) to be held in […]

Privacy Notice for California Residents

Effective Date: May 1st, 2019 This Privacy Notice for California Residents supplements and is expressly made part of the information contained in Abacus Health Product, Inc.’s https://abacushp.com/privacy-policy/ and applies solely to all visitors, users, and others who reside in the State of California (“consumers” or “you”). We adopt this Notice to comply with the California […]

Privacy Policy

Last modified: April 11, 2019 Introduction Abacus Health Products, Inc. (“Company” or “We”) respect your privacy and are committed to protecting it through our compliance with this policy. This policy describes the types of information we may collect from you or that you may provide when you visit the websites abacushp.com, cbdclinic.co, and cbd-medic.com as well […]

Terms Of Service

Last Modified: April 11, 2019 Acceptance of the Terms of Use These terms of use are entered into by and between You and Abacus Health Products, Inc. (“Company,” “we,” or “us”). The following terms and conditions, together with any documents they expressly incorporate by reference (collectively,  “Terms of Use”), govern your access to and use […]

Abacus Health Products Reports First Quarter 2019 Financial Results

Abacus Health Products Reports First Quarter 2019 Financial Results Toronto, ON – May 30, 2019 – Abacus Health Products, Inc. (CSE: ABCS) (“Abacus” or the “Company”) reported its financial results today for the first quarter ended March 31, 2019. All amounts are in U.S. dollars unless indicated otherwise. Q1 2019 Financial Summary Revenue increased 166% […]